Uziel Beller

4.1k total citations · 1 hit paper
68 papers, 3.0k citations indexed

About

Uziel Beller is a scholar working on Reproductive Medicine, Genetics and Surgery. According to data from OpenAlex, Uziel Beller has authored 68 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Reproductive Medicine, 19 papers in Genetics and 14 papers in Surgery. Recurrent topics in Uziel Beller's work include Ovarian cancer diagnosis and treatment (27 papers), BRCA gene mutations in cancer (15 papers) and Cancer Genomics and Diagnostics (6 papers). Uziel Beller is often cited by papers focused on Ovarian cancer diagnosis and treatment (27 papers), BRCA gene mutations in cancer (15 papers) and Cancer Genomics and Diagnostics (6 papers). Uziel Beller collaborates with scholars based in Israel, United States and United Kingdom. Uziel Beller's co-authors include Yoram Cohen, Ephrat Levy‐Lahad, Elizabeth Mambo, Zhihong Guo, Barry Trink, William H. Westra, Paul W. Ladenson, Mingzhao Xing, Bella Kaufman and Raphael Catane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Uziel Beller

68 papers receiving 2.9k citations

Hit Papers

BRAF Mutation in Papillary Thyroid Carcinoma 2003 2026 2010 2018 2003 200 400 600

Peers

Uziel Beller
J. Cuzick United Kingdom
Diana Fischer United States
Matthew F. Kohler United States
Barbara M. Norquist United States
Pierre O. Chappuis Switzerland
U. Beller Israel
J. Cuzick United Kingdom
Uziel Beller
Citations per year, relative to Uziel Beller Uziel Beller (= 1×) peers J. Cuzick

Countries citing papers authored by Uziel Beller

Since Specialization
Citations

This map shows the geographic impact of Uziel Beller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uziel Beller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uziel Beller more than expected).

Fields of papers citing papers by Uziel Beller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uziel Beller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uziel Beller. The network helps show where Uziel Beller may publish in the future.

Co-authorship network of co-authors of Uziel Beller

This figure shows the co-authorship network connecting the top 25 collaborators of Uziel Beller. A scholar is included among the top collaborators of Uziel Beller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uziel Beller. Uziel Beller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manchanda, Ranjit, K Loggenberg, Saskia C. Sanderson, et al.. (2014). Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial. JNCI Journal of the National Cancer Institute. 107(1). 379–379. 139 indexed citations
2.
Michaelson‐Cohen, Rachel, et al.. (2014). BRCA Mutation Carriers Do Not Have Compromised Ovarian Reserve. International Journal of Gynecological Cancer. 24(2). 233–237. 67 indexed citations
3.
Manchanda, Ranjit, K Loggenberg, Sue Gessler, et al.. (2012). Population based testing for high-penetrance dominant gene mutations: initial results from the pilot phase of GCaPPS. UCL Discovery (University College London). 2 indexed citations
4.
Gemer, Ofer, Ram Eitan, Michael Gdalevich, et al.. (2012). Can parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvement. European Journal of Surgical Oncology. 39(1). 76–80. 39 indexed citations
5.
Manchanda, Ranjit, Usha Menon, Rachel Michaelson‐Cohen, Uziel Beller, & Ian Jacobs. (2009). Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective. Current Opinion in Obstetrics & Gynecology. 21(1). 31–38. 16 indexed citations
6.
Carmon, Moshe, Oded Olsha, William P. Schecter, et al.. (2006). The “Sentinel Chain”: a new concept for prediction of axillary node status in breast cancer patients. Breast Cancer Research and Treatment. 97(3). 323–328. 5 indexed citations
7.
Shen, O., et al.. (2005). Number of yolk sacs does not predict amnionicity in early first‐trimester monochorionic multiple gestations. Ultrasound in Obstetrics and Gynecology. 27(1). 53–55. 27 indexed citations
8.
Grisaru‐Granovsky, Sorina, et al.. (2004). Differential expression of Protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. International Journal of Cancer. 113(3). 372–378. 93 indexed citations
9.
Hornreich, Gila, Uziel Beller, Ofer Lavie, et al.. (1999). Is Uterine Serous Papillary Carcinoma a BRCA1-Related Disease? Case Report and Review of the Literature. Gynecologic Oncology. 75(2). 300–304. 56 indexed citations
10.
Lavie, Ofer, et al.. (1996). Ultrasonographic “endometrial three-layer” pattern: A unique finding in ectopic pregnancy. Journal of Clinical Ultrasound. 24(4). 179–183. 13 indexed citations
11.
Fields, Scott, Eugene Libson, Ofer Lavie, & Uziel Beller. (1996). Renal cell carcinoma metastatic to the ovary ultrasound and CT appearance. Clinical Imaging. 20(1). 42–44. 10 indexed citations
12.
Lavie, Ofer, et al.. (1993). Maternal serum creatine kinase: A possible predictor of tubal pregnancy. American Journal of Obstetrics and Gynecology. 169(5). 1149–1150. 51 indexed citations
13.
Neuman, Menahem, et al.. (1992). Onset of spontaneous labor and changes in E2and progesterone levels — possible interrelation. Journal of Perinatal Medicine. 20(6). 429–435. 4 indexed citations
14.
Muggia, Franco M., Kenneth K. Chan, Christy Russell, et al.. (1991). Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2′-deoxyuridine. Cancer Chemotherapy and Pharmacology. 28(4). 241–250. 20 indexed citations
15.
Beller, Uziel, James L. Speyer, Nicoletta Colombo, et al.. (1991). Consolidation with intraperitoneal cisplatin in first-line therapy of advanced ovarian cancer.. Journal of Clinical Oncology. 9(5). 809–817. 11 indexed citations
16.
Peretz, Tamar, et al.. (1990). Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens. International Journal of Cancer. 45(6). 1054–1060. 10 indexed citations
17.
Green, Michael D., et al.. (1990). Phase II study of esorubicin (4 ′ deoxydoxorubicin) in anthracycline naive patients with ovarian cancer. Investigational New Drugs. 8(3). 333–336. 1 indexed citations
18.
Speyer, James L., Uziel Beller, Nicoletta Colombo, et al.. (1990). Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapy.. Journal of Clinical Oncology. 8(8). 1335–1341. 65 indexed citations
19.
Colombo, Nicoletta, James L. Speyer, Michael R. Green, et al.. (1989). Phase II study of carboplatin in recurrent ovarian cancer: severe hematologic toxicity in previously treated patients. Cancer Chemotherapy and Pharmacology. 23(5). 323–328. 14 indexed citations
20.
Beller, Uziel, et al.. (1988). Congenital arteriovenous malformation of the female pelvis: A gynecologic perspective. American Journal of Obstetrics and Gynecology. 159(5). 1153–1160. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026